The Cost of Obesity Drugs

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

The federal government this year put out a rule that is requiring insurers in that plan to cover at least one of these GLP1 drugs for obesity. That's a big change that adds a lot of people onto the coverage roles. A couple of states have actually started covering obesity drugs in recent years. So it does seem like things are changing incrementally.

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements in weight loss treatments–and the fight over who should pay for them. And Dr. Angela Fitch, a physician and president of the Obesity Medical Association, talks about the challenges of treating obesity.

Read their reporting here: Good Luck Paying for Those $10,000 Obesity Drugs Everyone’s Talking About

Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK

Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.

See omnystudio.com/listener for privacy information.